(Q57449177)

English

Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity (English)

0 references

J. Ludvigsson

1

0 references

publication date

13 November 2008

0 references

published in

Diabetologia

0 references

volume

52

0 references

issue

1

0 references

page(s)

175-176

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00125-008-1211-9

0 references

cites work

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19005640

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19005640

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of insulin in relatives of patients with type 1 diabetes mellitus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19005640

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19005640

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19005640

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19005640

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GAD treatment and insulin secretion in recent-onset type 1 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19005640

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19005640

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19005640

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00125-008-1211-9

0 references

PubMed publication ID

19005640

0 references

(Q57449177)

Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)